Analyst Update: Match, Teva Pharma, and Michael Kors

Analysts adjusted their ratings on Match Group Inc (NASDAQ:MTCH), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), and Michael Kors Holdings Ltd (KORS)

Nov 23, 2015 at 12:16 PM
facebook X logo linkedin

Analysts are weighing in today on Internet dating concern Match Group Inc (NASDAQ:MTCH), drug company Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and luxury retailer Michael Kors Holdings Ltd (NYSE:KORS). Here's a quick roundup of today's brokerage notes on MTCH, TEVA, and KORS.

  • MTCH was last seen trading at $14.87, a loss of 2.2%, after finishing Friday at a 27% premium to its $12.00 initial public offering (IPO) price on Thursday. Two brokerage firms initiated coverage on the shiny new stock today, with BTIG doling out a bearish "sell" rating and $11 price target, while Axiom gave Match Group Inc a bullish nod, with a "buy" rating and $18 price target. However, eager speculators will have to keep waiting before options can be traded on Match Group Inc.

  • TEVA received a rating boost to "buy" from "neutral" at Goldman Sachs, helping the shares climb 1.2% to $62.41 so far today. Teva Pharmaceutical Industries Ltd may be enjoying some extra attention thanks to major M&A news from sector peer Pfizer Inc. (NYSE: PFE). TEVA reported quarterly earnings above estimates last month, and has gained favor with analysts and options traders alike. Of the 17 firms following TEVA, 12 give it a "buy" rating or better. Even more impressive, the stock's 50-day call/put volume ratio on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 6.91 is higher than 93% of readings from the last 52 weeks -- meaning options buyers have rarely purchased calls over puts at a faster clip.

  • It's a good day on the charts so far for KORS, last seen up 1.7% to trade at $41.82, despite a price-target cut to $45 from $46 at Goldman Sachs. Michael Kors Holdings Ltd has been trending mostly sideways for months, ever since staging a late-May bear gap after earnings. The luxury brand beat quarterly earnings expectations earlier this month, but has yet to stage a convincing breakout above resistance at its 20-week moving average. As it stands, analysts are rather uncertain concerning the future of this stock, with 15 of the 19 brokerages following KORS maintaining a tepid "hold" rating, and just a few outliers on either side of the fence.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Horizon Pharma PLC, Panera Bread Co, and Microsoft Corporation, and Analyst Downgrades: Ambarella Inc, QUALCOMM, Inc., and Sunedison Inc.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI